NUS Nu Skin Enterprises, Inc. Common Stock
حول Nu Skin Enterprises, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
اقرأ المزيد
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
History
In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”
The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.
In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.
In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."
In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."
In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.
In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.
In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.
Products
Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.
In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.
Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.
Reception
Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.
In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."
In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".
In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.
In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.
In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.
In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.
In 2025, Nu Skin was named to USA Today's list of "best customer service."
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
NUS لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
NUS مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
| تاريخ الاستحقاق | المبلغ |
|---|---|
| 29 مايو، 2026 | $0,0600 |
| 27 فبراير، 2026 | $0,0600 |
| 28 نوفمبر، 2025 | $0,0600 |
| 29 أغسطس، 2025 | $0,0600 |
| 30 مايو، 2025 | $0,0600 |
| 24 فبراير، 2025 | $0,0600 |
| 29 نوفمبر، 2024 | $0,0600 |
| 30 أغسطس، 2024 | $0,0600 |
| 31 مايو، 2024 | $0,0600 |
| 23 فبراير، 2024 | $0,0600 |
| 22 نوفمبر، 2023 | $0,3900 |
| 24 أغسطس، 2023 | $0,3900 |
| 25 مايو، 2023 | $0,3900 |
| 24 فبراير، 2023 | $0,3900 |
| 23 نوفمبر، 2022 | $0,3850 |
| 25 أغسطس، 2022 | $0,3850 |
| 26 مايو، 2022 | $0,3850 |
| 25 فبراير، 2022 | $0,3850 |
| 24 نوفمبر، 2021 | $0,3800 |
| 26 أغسطس، 2021 | $0,3800 |
NUS توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 0 0,0%
- شراء 0 0,0%
- احتفاظ 3 37,5%
- بيع 4 50,0%
- بيع قوي 1 12,5%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $0.20 | $0.20 | -0.00% |
| 31 مارس، 2026 | $0.14 | $0.15 | -0.01% |
| 31 ديسمبر، 2025 | $0.29 | $0.30 | -0.01% |
| 30 سبتمبر، 2025 | $0.34 | $0.30 | 0.04% |
| 30 يونيو، 2025 | $0.43 | $0.25 | 0.18% |
| 31 مارس، 2025 | $0.23 | $0.13 | 0.10% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| NUS | — | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
| FTLF | — | 25.8 | 26.4% | — | — | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | |
| Cost of Revenue | $454M | $550M | $612M | $631M | $675M | $658M | $581M | $634M | $502M | $500M | $490M | |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | |
| R&D Expense | $11M | $13M | $23M | $23M | $27M | $23M | $30M | $23M | $22M | $24M | $20M | |
| SG&A Expense | $432M | $479M | $547M | $556M | $654M | $636M | $616M | $662M | $565M | $554M | $561M | |
| Operating Expenses | $966M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.80B | $1.50B | $1.48B | $1.51B | |
| Operating Income | $66M | $-152M | $48M | $111M | $234M | $258M | $267M | $241M | $274M | $231M | $245M | |
| Interest Expense | · | · | $26M | $14M | $11M | $13M | $19M | $22M | $22M | $16M | $8M | |
| Other Non-op | $-32M | $3M | $4M | $-8M | $-2M | $-1M | $-12M | $-21M | $-9M | $-18M | $-33M | |
| Pretax Income | $196M | $-175M | $27M | $89M | $232M | $256M | $255M | $220M | $266M | $213M | $212M | |
| Income Tax | $36M | $-28M | $18M | $-16M | $85M | $65M | $82M | $98M | $136M | $70M | $79M | |
| Net Income | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | $143M | $133M | |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | |
| Shares (Basic) | 49,293,000 | 49,662,000 | 49,711,000 | 50,002,000 | 50,193,000 | 52,296,000 | 55,518,000 | 55,170,000 | 52,806,000 | 55,412,000 | 57,997,000 | |
| Shares (Diluted) | 50,301,000 | 49,662,000 | 49,860,000 | 50,525,000 | 51,427,000 | 52,765,000 | 55,927,000 | 56,476,000 | 54,852,000 | 56,097,000 | 59,057,000 | |
| EBITDA | $118M | $-82M | $119M | $183M | $310M | $332M | $344M | $324M | $346M | · | $316M |
الميزانية العمومية 29
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239M | $187M | $256M | $265M | $340M | $403M | $336M | $387M | $426M | $357M | $289M | |
| Short-term Investments | $1M | $11M | $12M | $14M | $15M | $21M | $8M | $11M | $12M | $11M | $14M | |
| Receivables | $40M | $51M | $59M | $47M | $41M | $63M | $50M | · | · | · | · | |
| Inventory | $179M | $190M | $280M | $346M | $400M | $314M | $276M | $296M | $253M | $250M | $265M | |
| Prepaid Expense | $90M | $73M | $81M | $88M | $77M | $102M | $70M | $52M | $53M | $65M | $102M | |
| Other Current Assets | $13M | $14M | $18M | $18M | $18M | $15M | $16M | $16M | $14M | $13M | $14M | |
| Current Assets | $548M | $539M | $702M | $760M | $873M | $903M | $740M | $799M | $778M | $714M | $706M | |
| PP&E (Net) | $377M | $380M | $433M | $445M | $454M | $468M | $454M | $465M | $465M | $445M | $455M | |
| PP&E (Gross) | $768M | $733M | $788M | $787M | $819M | $818M | $785M | $788M | $751M | $678M | $666M | |
| Accum. Depreciation | $391M | $353M | $355M | $342M | $366M | $350M | $331M | $323M | $286M | $234M | $212M | |
| Goodwill | $84M | $84M | $218M | $206M | $206M | $203M | $197M | $197M | $115M | $115M | $112M | |
| Intangibles | $43M | $74M | $95M | $67M | $77M | $90M | $80M | $90M | $68M | $64M | $67M | |
| Other Non-current Assets | $280M | $298M | $248M | $244M | $175M | $138M | $154M | $144M | $165M | $136M | $165M | |
| Total Assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B | |
| Accounts Payable | $26M | $35M | $43M | $54M | $50M | $66M | $39M | $48M | $50M | $41M | $29M | |
| Accrued Liabilities | $218M | $218M | $254M | $280M | $372M | $447M | $290M | $323M | $319M | $275M | $311M | |
| Current Liabilities | $264M | $297M | $329M | $359M | $530M | $543M | $357M | $440M | $447M | $399M | $408M | |
| Capital Leases | $58M | $58M | $71M | $77M | $89M | $112M | $106M | $0 | · | · | · | |
| Deferred Tax | $310.0K | $345.0K | $522.0K | $439.0K | $2M | $626.0K | $11M | $18M | $37M | $643.0K | $16M | |
| Other Non-current Liabilities | $75M | $97M | $107M | $110M | $106M | $102M | $97M | $112M | $127M | $77M | $91M | |
| Total Liabilities | $600M | $817M | $987M | $924M | $994M | $1.06B | $894M | $913M | $885M | $810M | $680M | |
| Long-term Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | $417M | $254M | |
| Total Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | · | $250M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $1.86B | $1.71B | $1.87B | $1.94B | $1.91B | $1.84B | $1.73B | $1.64B | $1.61B | $1.56B | $1.49B | |
| Treasury Stock | $1.58B | $1.56B | $1.57B | $1.57B | $1.53B | $1.46B | $1.32B | $1.33B | $1.30B | $1.25B | $1.02B | |
| AOCI | $-116M | $-125M | $-100M | $-87M | $-74M | $-65M | $-85M | $-80M | $-66M | $-84M | $-71M | |
| Stockholders' Equity | $805M | $651M | $822M | $897M | $913M | $894M | $875M | $782M | $705M | $664M | $826M | |
| Liabilities + Equity | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B |
التدفق النقدي 19
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52M | $70M | $71M | $73M | $76M | $74M | $77M | $83M | $72M | $72M | $71M | |
| Stock-based Comp | $24M | $15M | $16M | $12M | $23M | $24M | $10M | $27M | $19M | $9M | $7M | |
| Deferred Tax | $20.0K | $-55M | $-15M | $-51M | $6M | $-14M | $-288.0K | $-19M | $44M | $-181.0K | $21M | |
| Amort. of Intangibles | $7M | $12M | $12M | $10M | $12M | $10M | $13M | $18M | $8M | $8M | $9M | |
| Restructuring | · | · | · | · | · | · | $22M | $22M | · | · | · | |
| Other Non-cash | $-156M | $229M | $39M | $-30M | $-112M | $104M | $-82M | $-10M | $38M | · | $90M | |
| Operating Cash Flow | $80M | $112M | $119M | $108M | $142M | $379M | $178M | $203M | $303M | $275M | $322M | |
| CapEx | $34M | $42M | $58M | $59M | $69M | $64M | $66M | $70M | $60M | $50M | $57M | |
| Investing Cash Flow | $171M | $-38M | $-135M | $-67M | $-89M | $-79M | $-71M | $-109M | $-92M | $-58M | $-61M | |
| Debt Issued | $55M | $15M | $110M | $460M | $155M | $115M | $145M | $582M | $67M | $234M | $36M | |
| Net Debt Issued | $-170M | $-110M | $100M | $28M | $40M | $-28M | $-69M | $30M | $-36M | · | $36M | |
| Stock Repurchased | $20M | $0 | $13M | $70M | $80M | $144M | $825.0K | $70M | $72M | $247M | $164M | |
| Net Stock Activity | $-20M | $0 | $-13M | $-70M | $-80M | $-144M | $-825.0K | $-70M | $-72M | · | $-164M | |
| Dividends Paid | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | $78M | $81M | |
| Financing Cash Flow | $-202M | $-133M | $11M | $-100M | $-105M | $-245M | $-155M | $-117M | $-160M | $-135M | $-236M | |
| Net Change in Cash | $52M | $-69M | $-9M | $-75M | $-63M | $67M | $-51M | $-39M | $69M | $68M | $939.0K | |
| Taxes Paid | $41M | $30M | $32M | $42M | $96M | $56M | $98M | $123M | $78M | $123M | $50M | |
| Free Cash Flow | $46M | $70M | $60M | $49M | $73M | $315M | $112M | $132M | $242M | · | $265M | |
| Levered FCF | · | · | $52M | $33M | $66M | $306M | $99M | $120M | $232M | · | $261M |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | · | · | |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.1% | 9.0% | 12.0% | · | · | |
| Net Margin | 10.8% | -8.5% | 0.44% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | · | · | |
| Pretax Margin | 13.2% | -10.1% | 1.4% | 4.0% | 8.6% | 9.9% | 10.5% | 8.2% | 11.7% | · | · | |
| EBITDA Margin | 8.0% | -4.7% | 6.0% | 8.2% | 11.5% | 12.8% | 14.2% | 12.1% | 15.2% | · | · | |
| ROA | 11.2% | -8.9% | 0.47% | 5.6% | 7.6% | 10.3% | 10.0% | 7.4% | 8.5% | · | 8.5% | |
| ROE | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% | 21.6% | 20.9% | 16.4% | 18.9% | · | 15.0% | |
| ROIC | 5.2% | -12.2% | 1.2% | 10.0% | 11.5% | 15.6% | 14.7% | 11.0% | 12.2% | · | 14.3% |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 | 1.7 | 2.1 | 1.8 | 1.7 | · | 1.7 | |
| Quick Ratio | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 1.0 | 0.9 | 1.0 | · | 0.7 | |
| Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | · | 0.3 | |
| LT Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | 1.9 | 8.2 | 21.3 | 19.7 | 13.9 | 11.0 | 12.4 | · | 31.0 |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.1 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.6 | 1.5 | · | · | |
| Inventory Turnover | 2.5 | 2.3 | 2.0 | 1.7 | 1.9 | 2.2 | 2.0 | 2.3 | 2.0 | · | 1.6 | |
| Receivables Turnover | 32.9 | 31.6 | 32.8 | 50.2 | 51.5 | 45.4 | · | · | · | · | · |
معدلات النمو 10
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.6% | -13.7% | -8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -91.8% | -27.6% | -21.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 15.4% | · | -63.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -91.8% | -28.8% | -23.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.2% | · | -64.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -31.5% | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 6
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | · | $2.25B | |
| Net Income TTM | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | · | $133M | |
| P/E | 3.0 | -2.3 | 114.2 | 20.4 | 17.7 | 15.0 | 13.2 | 28.4 | 28.9 | · | 16.8 | |
| Earnings Yield | 33.1% | -42.8% | 0.88% | 4.9% | 5.6% | 6.6% | 7.6% | 3.5% | 3.5% | · | 5.9% | |
| Payout Ratio | 7.4% | -8.1% | 903.1% | 73.5% | 51.8% | 41.0% | 47.4% | 66.1% | 58.8% | · | 61.0% | |
| Annual Payout | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | · | $81M |
قائمة الدخل 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $321M | $370M | $364M | $386M | $364M | $446M | $430M | $439M | $417M | $489M | $499M | $500M | $481M | $522M | $538M | |
| Cost of Revenue | $102M | $106M | $108M | $107M | $120M | $118M | $166M | $129M | $132M | $123M | $136M | $207M | $136M | $134M | $148M | $174M | |
| Gross Profit | $218M | $214M | $262M | $257M | $266M | $247M | $279M | $301M | $307M | $294M | $352M | $292M | $365M | $348M | $375M | $364M | |
| SG&A Expense | $91M | $99M | $107M | $105M | $107M | $113M | $121M | $116M | $118M | $125M | $145M | $131M | $137M | $134M | $128M | $138M | |
| Operating Expenses | $278M | $210M | $239M | $235M | $235M | $257M | $332M | $283M | $433M | $285M | $336M | $319M | $322M | $332M | $347M | $385M | |
| Operating Income | $-59M | $4M | $23M | $22M | $31M | $-10M | $-53M | $18M | $-126M | $9M | $16M | $-26M | $43M | $16M | $27M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $6M | $7M | $7M | · | $8M | $6M | $5M | · | · | |
| Other Non-op | $-534.0K | $3M | $-1M | $-2M | $-843.0K | $-28M | $1M | $2M | $629.0K | $-396.0K | $633.0K | $-551.0K | $376.0K | $3M | $10M | $-9M | |
| Pretax Income | $-63M | $3M | $18M | $16M | $27M | $135M | $-58M | $13M | $-132M | $1M | $9M | $-34M | $37M | $15M | $24M | $-29M | |
| Income Tax | $187M | $763.0K | $4M | $-1M | $6M | $27M | $-22M | $5M | $-13M | $2M | $2M | $3M | $10M | $3M | $-33M | $-4M | |
| Net Income | $-250M | $2M | $14M | $17M | $21M | $108M | $-36M | $8M | $-118M | $-533.0K | $7M | $-37M | $27M | $11M | $57M | $-25M | |
| EPS (Basic) | $-5.14 | $0.04 | $0.31 | $0.35 | $0.43 | $2.16 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | |
| EPS (Diluted) | $-5.14 | $0.04 | $0.27 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.15 | $-0.51 | |
| Shares (Basic) | 48,596,000 | 48,202,000 | -99,310,000 | 49,398,000 | 49,441,000 | 49,764,000 | -99,271,000 | 49,707,000 | 49,688,000 | 49,538,000 | -99,723,000 | 49,859,000 | 49,931,000 | 49,644,000 | -100,556,000 | 50,199,000 | |
| Shares (Diluted) | 48,596,000 | 49,422,000 | -99,836,000 | 50,310,000 | 49,499,000 | 50,328,000 | -99,297,000 | 49,733,000 | 49,688,000 | 49,538,000 | -100,218,000 | 49,859,000 | 50,161,000 | 50,058,000 | -101,700,000 | 50,199,000 | |
| EBITDA | $-47M | $16M | · | $34M | $44M | $4M | · | $36M | $-108M | $27M | · | $-8M | $60M | $33M | · | $-2M |
الميزانية العمومية 29
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190M | $199M | $239M | $252M | $264M | $204M | $187M | $228M | $224M | $213M | · | $233M | $236M | $230M | · | $294M | |
| Short-term Investments | $2M | $2M | $1M | $1M | $1M | $10M | $11M | $10M | $9M | $9M | · | $17M | $17M | $17M | · | $14M | |
| Receivables | $49M | $45M | $40M | $49M | $60M | $57M | $51M | $69M | $72M | $67M | · | $77M | $67M | $60M | · | $48M | |
| Inventory | $191M | $179M | $179M | $179M | $180M | $189M | $190M | $248M | $244M | $265M | · | $291M | $372M | $367M | · | $327M | |
| Prepaid Expense | $76M | $99M | $90M | $68M | $66M | $66M | $73M | $99M | $106M | $94M | · | $83M | $101M | $100M | · | $94M | |
| Other Current Assets | · | · | $13M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $508M | $523M | $548M | $548M | $572M | $525M | $539M | $653M | $654M | $647M | · | $701M | $793M | $774M | · | $778M | |
| PP&E (Net) | $380M | $382M | $377M | $375M | $374M | $380M | $380M | $411M | $412M | $423M | · | $429M | $430M | $438M | · | $433M | |
| PP&E (Gross) | · | · | $768M | · | · | · | $733M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $391M | · | · | · | $353M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $84M | $84M | $84M | $84M | $84M | $84M | $100M | $100M | $231M | · | $229M | $229M | $206M | · | $206M | |
| Intangibles | $38M | $39M | $43M | $44M | $46M | $48M | $74M | $85M | $88M | $102M | · | $109M | $113M | $65M | · | $69M | |
| Other Non-current Assets | $126M | $279M | $280M | $293M | $291M | $276M | $298M | $248M | $243M | $246M | · | $238M | $234M | $243M | · | $172M | |
| Total Assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B | |
| Accounts Payable | $38M | $29M | $26M | $29M | $29M | $34M | $35M | $33M | $36M | $32M | · | $49M | $50M | $49M | · | $42M | |
| Accrued Liabilities | $199M | $208M | $218M | $206M | $220M | $207M | $218M | $247M | $242M | $247M | · | $245M | $256M | $276M | · | $281M | |
| Current Liabilities | $256M | $257M | $264M | $254M | $284M | $260M | $297M | $339M | $309M | $309M | · | $434M | $445M | $373M | · | $366M | |
| Capital Leases | $50M | $54M | $58M | $62M | $62M | $62M | $58M | $68M | $70M | $74M | · | $68M | $74M | $79M | · | $78M | |
| Deferred Tax | · | · | $310.0K | · | · | · | $345.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $79M | $68M | $75M | $99M | $96M | $96M | $97M | $95M | $93M | $95M | · | $106M | $111M | $108M | · | $95M | |
| Total Liabilities | $579M | $583M | $600M | $625M | $656M | $637M | $817M | $876M | $900M | $932M | · | $971M | $998M | $932M | · | $921M | |
| Long-term Debt | $214M | $224M | $224M | $229M | $249M | $239M | $394M | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Total Debt | $214M | $224M | · | $229M | $249M | $239M | · | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | · | $91.0K | $91.0K | $91.0K | · | $91.0K | |
| Retained Earnings | $1.61B | $1.86B | $1.86B | $1.85B | $1.83B | $1.82B | $1.71B | $1.75B | $1.75B | $1.87B | · | $1.88B | $1.94B | $1.93B | · | $1.90B | |
| Treasury Stock | $1.56B | $1.56B | $1.58B | $1.57B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | · | $1.57B | $1.56B | $1.56B | · | $1.56B | |
| AOCI | $-118M | $-118M | $-116M | $-117M | $-114M | $-124M | $-125M | $-105M | $-117M | $-111M | · | $-109M | $-101M | $-91M | · | $-109M | |
| Stockholders' Equity | $543M | $794M | $805M | $800M | $788M | $754M | $651M | $707M | $686M | $810M | · | $822M | $895M | $893M | · | $842M | |
| Liabilities + Equity | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B |
التدفق النقدي 15
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $13M | $12M | $13M | $14M | $16M | $17M | $18M | $18M | $19M | $18M | $17M | $17M | $19M | $18M | |
| Stock-based Comp | $1M | $4M | $3M | $6M | $6M | $9M | $3M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $-22M | · | · | · | $-131M | · | · | · | $-19M | · | · | · | $-54M | · | · | |
| Operating Cash Flow | $11M | $-4M | $17M | $27M | $36M | $389.0K | $26M | $31M | $51M | $3M | $54M | $51M | $36M | $-22M | $26M | $28M | |
| CapEx | $6M | $14M | $11M | $10M | $18.0K | $14M | $13M | $9M | $8M | $12M | $20M | $12M | $15M | $11M | $14M | $25M | |
| Investing Cash Flow | $-6M | $-14M | $-10M | $-10M | $9M | $182M | $-14M | $-7M | $-9M | $-9M | $-15M | $-12M | $-93M | $-15M | $-13M | $-25M | |
| Debt Issued | $0 | $225M | $0 | $40M | $15M | $0 | $0 | $15M | $0 | $0 | $0 | $0 | $90M | $20M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-155M | · | · | · | $-20M | · | · | · | $18M | · | · | |
| Stock Repurchased | $0 | $5M | $10M | $5M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $13M | $0 | $0 | $10M | $40M | |
| Net Stock Activity | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Financing Cash Flow | $-13M | $-20M | $-19M | $-27M | $9M | $-166M | $-44M | $-29M | $-29M | $-32M | $-20M | $-38M | $68M | $1M | $-51M | $-61M | |
| Net Change in Cash | $-9M | $-40M | $-13M | $-12M | $60M | $17M | $-41M | $4M | $12M | $-44M | $23M | $-2M | $6M | $-35M | $-29M | $-70M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-9M | · | · | · | $-34M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
الربحية 8
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 66.9% | · | 70.5% | 68.8% | 67.8% | · | 70.1% | 70.0% | 70.5% | · | 58.6% | 72.9% | 72.2% | · | 67.7% | |
| Operating Margin | -18.5% | 1.3% | · | 5.9% | 8.0% | -2.7% | · | 4.2% | -28.6% | 2.1% | · | -5.3% | 8.5% | 3.3% | · | -3.8% | |
| Net Margin | -78.0% | 0.57% | · | 4.7% | 5.5% | 29.5% | · | 1.9% | -26.9% | -0.13% | · | -7.4% | 5.4% | 2.4% | · | -4.7% | |
| Pretax Margin | -19.7% | 0.81% | · | 4.4% | 7.1% | 36.9% | · | 3.1% | -30.0% | 0.26% | · | -6.9% | 7.4% | 3.0% | · | -5.4% | |
| EBITDA Margin | -14.6% | 5.1% | · | 9.3% | 11.3% | 1.2% | · | 8.3% | -24.6% | 6.5% | · | -1.6% | 11.9% | 6.9% | · | -0.39% | |
| ROA | -19.5% | 0.13% | · | 1.1% | 1.4% | 6.9% | · | 0.49% | -6.8% | -0.03% | · | -2.1% | 1.4% | 0.61% | · | -1.4% | |
| ROE | -37.5% | 0.24% | · | 2.3% | 2.9% | 13.8% | · | 1.1% | -15.0% | -0.06% | · | -4.4% | 2.9% | 1.2% | · | -2.9% | |
| ROIC | -31.0% | 0.28% | · | 2.2% | 2.3% | -0.80% | · | 1.0% | -9.8% | -0.33% | · | -2.1% | 2.2% | 0.95% | · | -1.4% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 2.2 | 2.0 | 2.0 | · | 1.9 | 2.1 | 2.1 | · | 1.6 | 1.8 | 2.1 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 1.0 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | 2.8 | -18.7 | 1.2 | · | · | · | · | · | · |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.5 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 5.9 | 6.3 | · | 6.2 | 5.9 | 5.9 | · | 5.9 | 6.3 | 6.6 | · | 8.0 | 9.0 | 8.6 | · | 10.7 |
التقييم (آخر 12 شهرًا) 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.39B | $1.44B | · | $1.54B | $1.62B | $1.65B | · | $1.79B | $1.86B | $1.90B | · | $2.02B | $2.08B | $2.18B | · | $2.34B | |
| Net Income TTM | $-210M | $148M | · | $154M | $19M | $-3M | · | $-147M | $-129M | $780.0K | · | $-24M | $47M | $59M | · | $97M | |
| P/E | -1.2 | 2.5 | · | 4.0 | 22.2 | -90.8 | · | -2.5 | -4.1 | 691.5 | · | -44.2 | 35.7 | 34.2 | · | 17.7 | |
| Earnings Yield | -82.0% | 40.5% | · | 25.3% | 4.5% | -1.1% | · | -40.2% | -24.6% | 0.14% | · | -2.3% | 2.8% | 2.9% | · | 5.7% | |
| Payout Ratio | · | 156.5% | · | · | · | 2.8% | · | · | · | -558.9% | · | · | · | 170.5% | · | · |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| هامش الربح الإجمالي % | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% |
| هامش الربح التشغيلي % | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| صافي الدخل | $160M | $-147M | $9M | $105M | $147M |
| EPS المخفف | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 |
| النسبة الحالية | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 |
| النسبة السريعة | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $46M | $70M | $60M | $49M | $73M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
- This $9 Nuclear Energy Stock Could Be Worth $100 by 2030
- ثلث الناس يؤمنون بأن درجة الجامعة ليست تستحق، مع بدء استفسار القروض الدراسية
- الطاقة النووية هي قصة الطاقة لعام 2026. إليك أسهمان يجب امتلاكهما طوال العام.
- NuScale Power مقابل Oklo: أي سهم نووي هو الأفضل للشراء في 2026؟
- أوكلو ضد نوسكيل باور في عام 2026. أيهما يستحق الشراء فعلاً؟
- 2 أسهم طاقة نووية للشراء في مايو
- توقع: سهم NuScale Power هو شراء قبل عام 2027 بسبب هذه الفرصة البالغة 1.75 تريليون دولار
- أبرز ما جاء في مكالمة أرباح Nu Skin Enterprises للربع الأول
- سهم NuScale Power انخفض بنسبة 82%. التاريخ يقول أن الناجين من مثل هذه الانهيارات يمكن أن يعودوا 5 مرات.
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 188 مقدمي إقرار · $157.3M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 34 (+13 مقابل الربع السابق) | 33 (+6 مقابل الربع السابق) | 51 (-14 مقابل الربع السابق) | 54 (-4 مقابل الربع السابق) | +4.8M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | $12150906 | 2301308 | 7,72% | الأسهم |
| Coppell Advisory Solutions LLC | $11266612 | 235 | 7,16% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $10822104 | 2049641 | 6,88% | الأسهم |
| Prescott Group Capital Management, L.L.C. | $9475530 | 1794608 | 6,02% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9170600 | 1736856 | 5,83% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $8926062 | 1690542 | 5,67% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $8488614 | 1607692 | 5,40% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7671507 | 1452937 | 4,88% | الأسهم |
| CastleKnight Management LP | $7337262 | 1389633 | 4,66% | الأسهم |
| TWO SIGMA ADVISERS, LP | $7314086 | 760300 | 4,65% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $6170388 | 1168634 | 3,92% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $5745042 | 1087765 | 3,65% | الأسهم |
| STATE STREET CORP | $5330941 | 1009648 | 3,39% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $3959403 | 749887 | 2,52% | الأسهم |
| CITADEL ADVISORS LLC | $3337140 | 632034 | 2,12% | الأسهم |
| Bank of New York Mellon Corp | $2377067 | 450202 | 1,51% | الأسهم |
| Allianz Asset Management GmbH | $2074074 | 392817 | 1,32% | الأسهم |
| D. E. Shaw & Co., Inc. | $1795385 | 340035 | 1,14% | الأسهم |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1674151 | 317074 | 1,06% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $1627908 | 308316 | 1,03% | الأسهم |
| Connor, Clark & Lunn Investment Management Ltd. | $1590690 | 301267 | 1,01% | الأسهم |
| AXA Investment Managers S.A. | $1307268 | 107241 | 0,83% | الأسهم |
| GOLDMAN SACHS GROUP INC | $1287735 | 243889 | 0,82% | الأسهم |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1212651 | 166573 | 0,77% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $1081872 | 204900 | 0,69% | الأسهم |
| VANGUARD GROUP INC | $1074333 | 111677 | 0,68% | الأسهم |
| Vanguard Global Advisers, LLC | $936603 | 177387 | 0,60% | الأسهم |
| FIRST TRUST ADVISORS LP | $925594 | 175302 | 0,59% | الأسهم |
| XTX Topco Ltd | $823379 | 155943 | 0,52% | الأسهم |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $803590 | 152195 | 0,51% | الأسهم |
| MARTINGALE ASSET MANAGEMENT L P | $799852 | 151487 | 0,51% | الأسهم |
| LAZARD ASSET MANAGEMENT LLC | $728614 | 137995 | 0,46% | الأسهم |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $670856 | 127056 | 0,43% | الأسهم |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $628125 | 118963 | 0,40% | الأسهم |
| ExodusPoint Capital Management, LP | $616408 | 116744 | 0,39% | الأسهم |
| Cubist Systematic Strategies, LLC | $571087 | 46849 | 0,36% | الأسهم |
| RITHOLTZ WEALTH MANAGEMENT | $527566 | 99918 | 0,34% | الأسهم |
| STRS OHIO | $511104 | 96800 | 0,32% | الأسهم |
| BlackRock, Inc. | $487228 | 92278 | 0,31% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $467376 | 64200 | 0,30% | الأسهم |
| Nebula Research & Development LLC | $460288 | 57608 | 0,29% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $425162 | 80523 | 0,27% | الأسهم |
| SummerHaven Investment Management, LLC | $402215 | 76177 | 0,26% | الأسهم |
| EP Wealth Advisors, LLC | $387314 | 73355 | 0,25% | الأسهم |
| BARCLAYS PLC | $375540 | 71125 | 0,24% | الأسهم |
| Skopos Labs, Inc. | $373217 | 51266 | 0,24% | الأسهم |
| Russell Investments Group, Ltd. | $372662 | 70580 | 0,24% | الأسهم |
| RHUMBLINE ADVISERS | $332444 | 62965 | 0,21% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $326631 | 61862 | 0,21% | الأسهم |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $323110 | 61195 | 0,21% | الأسهم |
| Engineers Gate Manager LP | $314688 | 59600 | 0,20% | الأسهم |
| Campbell & CO Investment Adviser LLC | $299571 | 56737 | 0,19% | الأسهم |
| Graham Capital Management, L.P. | $297649 | 56373 | 0,19% | الأسهم |
| Cambria Investment Management, L.P. | $283969 | 53782 | 0,18% | الأسهم |
| EXCHANGE TRADED CONCEPTS, LLC | $281276 | 53272 | 0,18% | الأسهم |
| FEDERATED HERMES, INC. | $276213 | 52313 | 0,18% | الأسهم |
| WOLVERINE TRADING, LLC | $264769 | 21918 | 0,17% | الأسهم |
| DGS Capital Management, LLC | $263128 | 36144 | 0,17% | الأسهم |
| Quantinno Capital Management LP | $259888 | 49221 | 0,17% | الأسهم |
| DEUTSCHE BANK AG\ | $251391 | 47612 | 0,16% | الأسهم |
| Walleye Capital LLC | $248947 | 47149 | 0,16% | الأسهم |
| CWM, LLC | $242924 | 33369 | 0,15% | الأسهم |
| State of Tennessee, Department of Treasury | $227648 | 43115 | 0,14% | الأسهم |
| AMERIPRISE FINANCIAL INC | $225055 | 42624 | 0,14% | الأسهم |
| Aquatic Capital Management LLC | $223634 | 42355 | 0,14% | الأسهم |
| MANGROVE PARTNERS IM, LLC | $222198 | 42083 | 0,14% | الأسهم |
| WELLS FARGO & COMPANY/MN | $215783 | 40868 | 0,14% | الأسهم |
| Verdad Advisers, LP | $195355 | 36999 | 0,12% | الأسهم |
| FMR LLC | $173791 | 32915 | 0,11% | الأسهم |
| Y-Intercept (Hong Kong) Ltd | $172767 | 32721 | 0,11% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $170544 | 32300 | 0,11% | الأسهم |
| Range Financial Group LLC | $167666 | 31755 | 0,11% | الأسهم |
| State of Wyoming | $161019 | 30496 | 0,10% | الأسهم |
| Abel Hall, LLC | $149112 | 28241 | 0,09% | الأسهم |
| Empowered Funds, LLC | $146351 | 27718 | 0,09% | الأسهم |
| WOLVERINE TRADING, LLC | $143752 | 11900 | 0,09% | عقد خيار البيع |
| MetLife Investment Management, LLC | $140765 | 26660 | 0,09% | الأسهم |
| Atom Investors LP | $140078 | 26530 | 0,09% | الأسهم |
| Susquehanna Portfolio Strategies, LLC | $139561 | 26432 | 0,09% | الأسهم |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $131604 | 24925 | 0,08% | الأسهم |
| HSBC HOLDINGS PLC | $127773 | 24619 | 0,08% | الأسهم |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $121567 | 23024 | 0,08% | الأسهم |
| Vanguard Personalized Indexing Management, LLC | $120410 | 22805 | 0,08% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $118642 | 22470 | 0,08% | الأسهم |
| Creative Planning | $116686 | 22100 | 0,07% | الأسهم |
| Advisors Asset Management, Inc. | $115366 | 16744 | 0,07% | الأسهم |
| Aigen Investment Management, LP | $104137 | 19723 | 0,07% | الأسهم |
| CITIGROUP INC | $103889 | 19676 | 0,07% | الأسهم |
| Invesco Ltd. | $102585 | 19429 | 0,07% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $100848 | 19100 | 0,06% | عقد خيار البيع |
| GLENMEDE TRUST CO NA | $100541 | 19042 | 0,06% | الأسهم |
| CITADEL ADVISORS LLC | $98736 | 18700 | 0,06% | عقد خيار البيع |
| AlphaQuest LLC | $95748 | 9953 | 0,06% | الأسهم |
| Schonfeld Strategic Advisors LLC | $78908 | 14945 | 0,05% | الأسهم |
| Jain Global LLC | $76032 | 14400 | 0,05% | الأسهم |
| MEEDER ASSET MANAGEMENT INC | $72975 | 13821 | 0,05% | الأسهم |
| Police & Firemen's Retirement System of New Jersey | $72695 | 13768 | 0,05% | الأسهم |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $72107 | 13787 | 0,05% | الأسهم |
| BANK OF MONTREAL /CAN/ | $70504 | 13353 | 0,04% | الأسهم |
| PharVision Advisers, LLC | $69707 | 13202 | 0,04% | الأسهم |
المطلعون على الشركة 57 من المطلعين · مسؤولون 31 · مديرون 25
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Ryan S Napierski | President and CEO | 6 مارس، 2026 A | 1001905 | 0 | 0 | $0 |
| Ritch N Wood | Chief Executive Officer | 17 يونيو، 2021 S | 175239 | 0 | 0 | $0 |
| Truman M Hunt | President & CEO | 27 فبراير، 2017 A | 575559 | 0 | 0 | $0 |
| James D Thomas | Chief Financial Officer | 6 مارس، 2026 A | 267102 | 0 | 0 | $0 |
| Mark H Lawrence | Chief Financial Officer | 2 مارس، 2023 M | 57146 | 0 | 0 | $0 |
| Scott E Schwerdt | President, Americas Region | 18 ديسمبر، 2015 A | 34585 | 0 | 0 | $0 |
| Gary Sumihiro | President | 20 ديسمبر، 2007 A | 800 | 0 | 0 | $0 |
| Luke Loo | President | 20 ديسمبر، 2007 A | 5625 | 0 | 0 | $0 |
| Larry V Macfarlane | President, Big Planet | 26 فبراير، 2007 A | 6005 | 0 | 0 | $0 |
| Robert S Conlee | President, North Asia & Japan | 26 فبراير، 2007 A | 4549 | 0 | 0 | $0 |
| Lori H Bush | President -Nu Skin Division | 31 أغسطس، 2005 A | 11453 | 0 | 0 | $0 |
| Chayce David Clark | EVP, COO and CLO | 6 مارس، 2026 A | 390746 | 0 | 1 | $-239400 |
| Justin S Keisel | EVP, President of Global Sales | 6 مارس، 2026 A | 160170 | 0 | 0 | $0 |
| Steven Keith Hatchett | Chief Product Officer | 6 مارس، 2026 A | 260818 | 1 | 0 | $52855 |
| Connie Mang Yee Tang | Chief Global Growth Officer | 21 إبريل، 2023 F | 43204 | 0 | 0 | $0 |
| Joseph Y Chang | Chief Scientific Officer | 2 مارس، 2023 M | 21234 | 0 | 0 | $0 |
| Steven Lund | Exec. Chairman of the Board | 1 مارس، 2023 G | 113574 | 0 | 0 | $0 |
| Jeffrey Clark Bettinger | SVP, People and Places Officer | 5 أكتوبر، 2021 S | 16068 | 0 | 0 | $0 |
| Matthew D Dorny | General Counsel | 2 يوليو، 2021 M | 47159 | 0 | 0 | $0 |
| Daniel R Chard | Pres Global Sales & Operations | 6 يوليو، 2015 M | 48111 | 0 | 0 | $0 |
| Blake Roney | Chairman of the Board | 3 يونيو، 2011 G | 3216458 | 0 | 0 | $0 |
| Ashok Pahwa | Chief Marketing Officer | 28 أغسطس، 2009 F | 3322 | 0 | 0 | $0 |
| Jack Peterson | Vice President | 20 ديسمبر، 2007 A | 6984 | 0 | 0 | $0 |
| Mark L Adams | Chief Information Officer | 20 ديسمبر، 2007 A | 11410 | 0 | 0 | $0 |
| Claire Averett | Vice President | 4 سبتمبر، 2007 F | 3230 | 0 | 0 | $0 |
| Brett Nelson | Vice President | 4 سبتمبر، 2007 F | 4202 | 0 | 0 | $0 |
| Corey B Lindley | Executive Vice President | 1 سبتمبر، 2006 A | 20750 | 0 | 0 | $0 |
| Mark Wolfert | Regional Vice President- | 31 أغسطس، 2005 A | 0 | 0 | 0 | $0 |
| Michael D Smith | Vice President-Gov't Relations | 31 أغسطس، 2005 A | 1734 | 0 | 0 | $0 |
| Richard W King | Chief Information Officer | 31 أغسطس، 2005 A | 5987 | 0 | 0 | $0 |
| Brooke Roney | Senior Vice President | 2 ديسمبر، 2004 G | 825000 | 0 | 0 | $0 |
| Edwina D Woodbury | مدير | 10 يونيو، 2026 A | 62452 | 0 | 1 | $-41057 |
| James M Winett | مدير | 2 يونيو، 2026 S | 37448 | 0 | 1 | $-40481 |
| Laura Nathanson | مدير | 1 يونيو، 2026 A | 57116 | 0 | 2 | $-97305 |
| Emma S. Battle | مدير | 1 يونيو، 2026 A | 57648 | 0 | 0 | $0 |
| Pisano R. Thomas | مدير | 1 يونيو، 2026 A | 116827 | 0 | 0 | $0 |
| Mark A Zorko | مدير | 1 يونيو، 2026 A | 60586 | 0 | 0 | $0 |
| Daniel W Campbell | مدير | 1 يونيو، 2026 A | 65859 | 0 | 2 | $-392669 |
| Zheqing Shen | مدير | 7 يونيو، 2024 A | 33195 | 0 | 0 | $0 |
| Andrew D Lipman | مدير | 28 مايو، 2024 S | 23225 | 0 | 0 | $0 |
| Neil H Offen | مدير | 21 مايو، 2019 M | 10083 | 0 | 0 | $0 |
| Nevin N Andersen | مدير | 21 مايو، 2019 M | 34045 | 0 | 0 | $0 |
| Zhequing Shen | مدير | 11 مايو، 2017 A | 3456 | 0 | 0 | $0 |
| Patricia Negron | مدير | 13 مايو، 2015 G | 7592 | 0 | 0 | $0 |
| Sandra Tillotson | مدير | 4 مايو، 2012 M | 1885845 | 0 | 0 | $0 |
| David D. Ussery | مدير | 9 فبراير، 2012 M | 13222 | 0 | 0 | $0 |
| Ej Jake Garn | مدير | 24 مايو، 2011 A | 17272 | 0 | 0 | $0 |
| Desmond C Wong | مدير | 15 مايو، 2007 A | 1400 | 0 | 0 | $0 |
| Christine Mccormick Day | مدير | 15 مايو، 2007 A | 1400 | 0 | 0 | $0 |
| Allen D Andersen | مدير | 25 مايو، 2006 A | 2500 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 9 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 11 فبراير، 2008 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 2 إبريل، 2007 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 26 مارس، 2007 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 15 مارس، 2007 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 8 ديسمبر، 2006 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 9 يونيو، 2006 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 8 مايو، 2006 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 20 يناير، 2006 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 15 ديسمبر، 2005 | — | إيداع أولي | استثمار سلبي | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 47 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| DEEP · ETF Series Solutions | 0,71% | 32178 NS | 31 مايو، 2026 | N-PORT |
| MYLD · Cambria ETF Trust | 0,62% | 25194 NS | 30 إبريل، 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,37% | 62972 NS | 31 مايو، 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,37% | 103377 NS | 31 مايو، 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 113111 NS | 30 إبريل، 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 123628 SH | 8 أغسطس، 2026 | يومي |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 1220658 NS | 31 مايو، 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 51988 SH | 8 أغسطس، 2026 | يومي |
| IWC · iShares Trust | 0,06% | 164733 SH | 8 أغسطس، 2026 | يومي |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,04% | 1939936 NS | 31 مايو، 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 63063 NS | 31 مايو، 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 0,03% | 570468 SH | 8 أغسطس، 2026 | يومي |
| EBIT · Harbor ETF Trust | 0,03% | 435 NS | 30 إبريل، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,02% | 242807 NS | 30 إبريل، 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 42579 SH | 8 أغسطس، 2026 | يومي |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 90212 NS | 31 مايو، 2026 | N-PORT |
| IWN · iShares Trust | 0,02% | 492546 SH | 8 أغسطس، 2026 | يومي |
| DFAT · Dimensional ETF Trust | 0,01% | 253656 NS | 30 إبريل، 2026 | N-PORT |
| SMLF · iShares Trust | 0,01% | 108807 SH | 8 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,01% | 20906 NS | 30 إبريل، 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 280867 SH | 8 أغسطس، 2026 | يومي |
| SFGV · EA Series Trust | 0,01% | 27758 NS | 29 مايو، 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1306883 SH | 8 أغسطس، 2026 | يومي |
| DFAS · Dimensional ETF Trust | 0,01% | 161524 NS | 30 إبريل، 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2272 NS | 31 مايو، 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 13837 NS | 31 مايو، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 236168 NS | 31 مايو، 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1776 NS | 31 مايو، 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1999 NS | 30 إبريل، 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1797 NS | 31 مايو، 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 33427 SH | 8 أغسطس، 2026 | يومي |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 38038 NS | 31 مايو، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1714 NS | 31 مايو، 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 1031 NS | 31 مايو، 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 45 NS | 31 مايو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4155 NS | 30 إبريل، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2509 NS | 30 إبريل، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10479 NS | 30 إبريل، 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69546 SH | 8 أغسطس، 2026 | يومي |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27870 NS | 31 مايو، 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12071 SH | 8 أغسطس، 2026 | يومي |
| DFUS · Dimensional ETF Trust | 0,00% | 6548 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 562165 SH | 8 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1465550 SH | 8 أغسطس، 2026 | يومي |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3734 SH | 8 أغسطس، 2026 | يومي |
| EBI · RBB Fund Trust | 0,00% | 3 NS | 31 مايو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1362 NS | 30 إبريل، 2026 | N-PORT |